KK Therapeutics ApS
CVR 40378111 · Private limited company (ApS) · Dissolved by declaration
KK Therapeutics ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry fremstilling af farmaceutiske præparater. The company is no longer active (status: dissolved by declaration). 1 annual report has been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2019) shows equity of DKK 17k and a net result of DKK -33k.
Company details
- CVR number
- 40378111
- Status
- Dissolved by declaration
- Company type
- Private limited company (ApS)
- Founded
- Ceased
- Address
- c/o Karl Agger, Amagerbrogade 18, 1. th
2300 København S - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 50k
- Auditor
- Revinord
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 73.4% |
| Current ratio | – |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 13 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2019 | 2018 |
|---|---|---|
| Gross profit | DKK -30k | DKK 0 |
| Net profit | DKK -33k | DKK 0 |
| Equity | DKK 17k | DKK 0 |
| Total assets | DKK 23k | DKK 0 |
| Cash | DKK 23k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Revinord.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 21 Mar 2019 – 31 Dec 2019 | 243 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Karl Agger | ||
| CEO | Kristian Helin | ||
| Owner (50%) | Karl Agger | ||
| Owner (50%) | Kristian Helin | ||
| Founder | Karl Agger | ||
| Founder | Kristian Helin |
The CEOs' other companies
Kristian Helin – 3 other companies
- Dania Therapeutics ApS Active
- EPITHERAPEUTICS ApS Opløst
- HELIN HOLDING ApS Opløst
Address history (1 moves)
| c/o Karl Agger, Amagerbrogade 18, 1. th, 2300 København S | |
| c/o Karl Agger, Amagerbrogade 18, st. 1, 2300 København S |
Other companies at the same address
- Dinhelsebix-go4love ApS Bankrupt
- MAR ApS Bankrupt
- ZANZ ApS Bankrupt
- 4 Love 2 42 ApS Active
- AMAGERBRO TANDKLINIK ApS Active
- BORK-NIELSEN EJENDOMME ApS Opløst
- J.K.J. HUSET ApS Compulsorily dissolved
- JOH. BRUHN & CO. ApS Opløst
- PONTOPS ApS Opløst
- Pontops 4 Love 2 Learn ApS Active
- Pontops Consulting ApS Opløst
- RASMUS BORK-NIELSEN HOLDING ApS Opløst
- VINOS LOS ANDES ApS Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about KK Therapeutics ApS
Has KK Therapeutics ApS gone bankrupt?
No, KK Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: dissolved by declaration.
Who is the auditor of KK Therapeutics ApS?
KK Therapeutics ApS most recently used Revinord.
When was KK Therapeutics ApS founded?
KK Therapeutics ApS was founded on 21 March 2019.
What is the equity of KK Therapeutics ApS?
Equity was DKK 17k according to the annual report for the period ending 31 December 2019.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.